Koga, M.
Kinoshita, Y.
Kato, H.
Kobayashi, H.
Shinoda, Y.
Nangaku, M.
Makita, N.
Dahir, K. M.
Funding for this research was provided by:
Japan Society for the Promotion of Science (KAKENHI 18K09018)
Article History
Received: 20 May 2021
Accepted: 2 September 2021
First Online: 8 September 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. The study protocols were approved by the institutional review board of the University of Tokyo (approval number: G10115).
: Informed consent was obtained from all individual participants included in the study.
: Kathryn M Dahir is a clinical trial investigator and a consultant for Alexion pharmaceuticals. Minae Koga, Yuka Kinoshita, Hajime Kato, Hiroshi Kobayashi, Yusuke Shinoda, Masaomi Nangaku, Noriko Makita, and Nobuaki Ito declare that they have no conflict of interest.